Assertio Therapeutics's total assets for Q3 2025 were $319.77M, an increase of 16.80% from the previous quarter. ASRT total liabilities were $213.97M for the fiscal quarter, a 18.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.